Position in PFE
as of Jun 30, 2026
· filed Jul 10, 2026
Position Value
$323,225
-$97,553 QoQ
Shares Held
13,423
-10.4% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#2,074
of 2,821 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026WEDGE CAPITAL MANAGEMENT L L P/NC holds $67,797,573 across 8 Drug Manufacturers - General names. PFE ranks #6 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
134,579 | $33,865,459 | |
| 2 | BMY |
Bristol Myers Squibb Co
|
528,057 | $30,426,644 | |
| 3 | JNJ |
Johnson & Johnson
|
4,295 | $1,090,801 | |
| 4 | LLY |
ELI LILLY & Co
|
764 | $916,364 | |
| 5 | MRK |
Merck & Co., Inc.
|
4,873 | $626,180 | |
| 6 | PFE |
Pfizer Inc
This page
|
13,423 | $323,225 | |
| 7 | AMGN |
Amgen Inc
|
840 | $304,180 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
1,937 | $244,720 |
All Filings in PFE
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $323,225 | 13,423 | Shares | Sole | 2026-07-10 | |
| 2026-03-31 | $420,778 | 14,985 | Shares | Sole | 2026-04-13 | |
| 2025-12-31 | $28,414,958 | 1,141,163 | Shares | Sole | 2026-01-14 | |
| 2025-09-30 | $26,912,969 | 1,056,239 | Shares | Sole | 2025-10-10 | |
| 2025-06-30 | $31,081,958 | 1,282,259 | Shares | Sole | 2025-07-11 | |
| 2025-03-31 | $31,865,632 | 1,257,523 | Shares | Sole | 2025-04-14 | |
| 2024-12-31 | $29,215,499 | 1,101,225 | Shares | Sole | 2025-01-15 | |
| 2024-09-30 | $32,273,916 | 1,115,201 | Shares | Sole | 2024-10-11 | |
| 2024-06-30 | $34,188,426 | 1,221,888 | Shares | Sole | 2024-07-17 | |
| 2023-12-31 | $311,392 | 10,816 | Shares | Sole | 2024-02-01 | |
| 2023-09-30 | $360,392 | 10,865 | Shares | Sole | 2023-10-13 | |
| 2023-06-30 | $360,234 | 9,821 | Shares | Sole | 2023-07-17 | |
| 2023-03-31 | $411,916 | 10,096 | Shares | Sole | 2023-04-11 | |
| 2022-12-31 | $508,300 | 9,920 | Shares | Sole | 2023-01-17 | |
| 2022-09-30 | $427,403 | 9,767 | Shares | Sole | 2022-10-13 | |
| 2022-06-30 | $514,915 | 9,821 | Shares | Sole | 2022-07-11 | |
| 2022-03-31 | $34,335,520 | 663,232 | Shares | Sole | 2022-04-12 | |
| 2021-12-31 | $34,909,828 | 591,191 | Shares | Sole | 2022-01-24 | |
| 2021-09-30 | $29,333,207 | 682,009 | Shares | Sole | 2021-10-14 | |
| 2021-06-30 | $30,955,745 | 790,494 | Shares | Sole | 2021-07-14 | |
| 2021-03-31 | $32,603,703 | 899,909 | Shares | Sole | 2021-04-12 | |
| 2020-12-31 | $26,745,888 | 726,593 | Shares | Sole | 2021-01-08 | |
| 2020-09-30 | $27,419,203 | 747,118 | Shares | Sole | 2020-10-08 | |
| 2020-06-30 | $33,304,395 | 1,018,482 | Shares | Sole | 2020-07-10 | |
| 2020-03-31 | $33,143,394 | 1,015,424 | Shares | Sole | 2020-04-13 | |
| No filing history on record for this holder in this stock. | ||||||